The combination of hormone-based drugs can produce enhanced weight loss in laboratory tests with obese animals.
Dr. Matthew Hayes and his team studied the combination of two different drug classes that target different hormones: amylin and glucagon-like peptide-1 (GLP-1). They found that combined treatments acted synergistically to suppress feeding and body weight.
They also discovered that the weight loss effects of chronic amylin- and GLP-1-based combination therapies could be enhanced when ...
The combination of hormone-based drugs can produce enhanced weight loss in laboratory tests with obese animals.
Dr. Matthew Hayes and his team studied the combination of two different drug classes that target different hormones: amylin and glucagon-like peptide-1 (GLP-1). They found that combined treatments acted synergistically to suppress feeding and body weight.
They also discovered that the weight loss effects of chronic amylin- and GLP-1-based combination therapies could be enhanced when ...